Cargando…
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope
The objective of this guideline is to provide up-to-date, evidence-based recommendations for the management of SLE that builds upon the existing treatment guideline for adults living with SLE published in 2017. This will incorporate advances in the assessment, diagnosis, monitoring, non-pharmacologi...
Autores principales: | Md Yusof, Md Yuzaiful, Smith, Eve M D, Ainsworth, Sammy, Armon, Kate, Beresford, Michael W, Brown, Morgan, Cherry, Lindsey, Edwards, Christopher J, Flora, Kalveer, Gilman, Rebecca, Griffiths, Bridget, Gordon, Caroline, Howard, Paul, Isenberg, David, Jordan, Natasha, Kaul, Arvind, Lanyon, Peter, Laws, Philip M, Lightsone, Liz, Lythgoe, Hanna, Mallen, Christian D, Marks, Stephen D, Maxwell, Naomi, Moraitis, Elena, Nash, Clare, Pepper, Ruth J, Pilkington, Clarissa, Psarras, Antonios, Rostron, Heather, Skeates, Jade, Skeoch, Sarah, Tremarias, Dalila, Wincup, Chris, Zoma, Asad, Vital, Edward M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695902/ http://dx.doi.org/10.1093/rap/rkad093 |
Ejemplares similares
-
Early intervention in systemic lupus erythematosus: time for action to improve outcomes and health-care utilization
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2021) -
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity
por: Psarras, Antonios, et al.
Publicado: (2020) -
Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab
por: Hassan, Sabih Ul, et al.
Publicado: (2020) -
Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2018) -
Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2022)